Methylphenidate Hcl Articles
Celgene swings back to profit in 1st qtr
5 May 2009
J&J 1st qtr hit by market drop; keeps guidance
15 April 2009
Celgene's 3rd-qtr profit triples on drug sales
17 November 2008
One-in-five in the USA could have Ritalin for non-medical use
20 October 2008
UK's NICE says "Yes" to some drugs
29 September 2008
Celgene profits double on rocketing sales
11 August 2008
Focalin XR manages ADHD better than Concerta ER
21 July 2008
DEA block to US e-Rx adoption set to end
30 June 2008
Illegal California pharmacy faces charges
2 June 2008
Celgene posts 1st-qtr loss on Pharmion costs
19 May 2008
Florida Detox urges new depression classification
25 February 2008
J&J's 4th-qtr 2007 sales jump 16.6%, EPS up 11%
28 January 2008
Celgene's
14 January 2008
ADHD drug benefits "exaggerated," report claims
19 November 2007
Barr confirms patent challenge to Novartis Ritalin
12 November 2007
Celegene's 2nd-qtr 2007 income soars 187.2%
6 August 2007
Celgene's 1st-qtr 2007 net income soars 61.4%
28 May 2007
Lilly's Strattera added to Australian PBS
30 April 2007
J&J's Concerta "less potential for abuse"
6 November 2006
Doctor-patient communication and pressure under scrutiny
2 October 2006
ADD and ADHD
7 August 2006
UK science chief advocates "smart drugs"
12 June 2006
Australia calls for info on ADHD drugs
1 May 2006
Japan to discuss pediatric drug use
10 April 2006
US FDA urged to warn on ADHD drugs
20 February 2006
McNeil to co-promote modafinil for ADHD with Cephalon
5 September 2005
Australian PBS adds 45 drugs, widens use for 28
8 August 2005
Andrx reports 33% income rise
16 May 2005
Celgene posts record 1st-qtr EPS
9 May 2005
Lilly adds liver warning to Strattera label
10 January 2005
US FDA approved Concerta Extended-release CII for ADHD
1 November 2004
Celgene's profits below forecast
19 January 2004
Celgene forecasts profit in 2003
17 March 2003
Novartis' Ritalin LA cleared in USA
17 June 2002
Novartis' Ritalin LA cleared in USA
17 June 2002
Ritalin suit dismissed
18 March 2002
Janssen gets OK for Concerta XL in UK
4 March 2002
Novel formulations set to drive ADHD market, study finds
11 February 2002
Ritalin may have long-term effects on brain
16 November 2001
Ritalin line extension approved in USA
16 November 2001
FDA OKs Novatis/Celgene's once-daily Ritalin
4 October 2001
Datamonitor expresses views on Celebrex vs Vioxx; Novartis ADHD drug
24 September 2001
Novartis' Ritadex is "approvable" in USA
23 August 2001
Puerto Rico plaintiffs drop Ritalin action
22 August 2001
US state acts on school use of psychiatric drugs
20 July 2001
Biovail files for single-isomer ADHD drug in Canada
12 July 2001
Ritalin lawsuit against Novartis dismissed
22 May 2001
PhRMA, others act as Rx drug abuse grows
12 April 2001
Judge questions complaint against Novartis over Ritalin
15 March 2001
Celgene lifted by new version of ADHD drug
2 January 2001
Novartis ties up with Cephalon in UK marketing pact
7 December 2000
Medeva enters ADHD once-daily race
27 October 2000
Eli Lilly reveals novel therapy for ADHD
27 October 2000
Novartis rejects Ritalin charges in the USA
19 September 2000
Novartis rejects Ritalin charges in the USA
15 September 2000
Novartis named in Ritalin lawsuits
14 September 2000
Mallinckrodt wins FDA OK for Methylin ER
18 May 2000
Clintons act to cut Rxing for under-7s
22 March 2000
Novartis says 25% chance Zelmac NDA will not be accepted
22 February 2000
Noven plans 2001 filing for ADHD patch
3 June 1999
-Canada approves Celgene Corp's IND for chirally-specific Ritalin.
18 February 1999
UK's Medeva Redefining Product Portfolio
18 February 1998
Johnson Matthey's Methylphenidate Approved In USA
4 September 1997
Clinton Plans New Rules On Child Drug Safety
19 August 1997
Shire To Merge With Richwood In $186m Takeover
6 August 1997
Medeva's Growth Dulled By "Fen-Phen" Effect
17 July 1997
Celgene Submits IND for New Form Of ADHD Drug
13 January 1997
New Player Enters US Attention Deficit Market
4 March 1996
FDA Links Methylphenidate Products To Cancer
22 January 1996
Johnson Matthey Enters ADD Arena
22 May 1995
Eight-Year-Old Cephalon Integrates For Success
22 May 1995
RITALIN PRODUCTION HIKE REQUEST STALL
22 November 1993
RITALIN SHORTAGE SET TO CONTINUE
1 November 1993
RITALIN SHORTAGES
25 October 1993
Showing 1-85 of 85 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
